日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

AXL-SHC1 signaling axis mediates adaptive resistance to HER2-targeted tyrosine kinase inhibitors in HER2-aberrant lung and gastric cancers

AXL-SHC1信号轴介导HER2异常肺癌和胃癌对HER2靶向酪氨酸激酶抑制剂的适应性耐药

Ishida, Masaki; Yamada, Tadaaki; Katayama, Yuki; Kawachi, Hayato; Sawada, Ryo; Nakamura, Ryota; Hirai, Soichi; Matsui, Yohei; Morimoto, Kenji; Onoi, Keisuke; Nakamura-Sasada, Aosa; Horinaka, Mano; Sakai, Toshiyuki; Sakakida, Tomoki; Doi, Toshifumi; Yasumoto, Kazuo; Goto, Yasuhiro; Furuya, Naoki; Taniguchi, Hirokazu; Ogino, Hirokazu; Takayuki, Nakano; Chihara, Yusuke; Fukuda, Koji; Taniguchi, Hiroaki; Uehara, Hisanori; Yano, Seiji; Tokuda, Shinsaku; Takayama, Koichi

MET Enhances Amivantamab Binding to EGFR and Antibody-Dependent Cellular Toxicity

MET增强Amivantamab与EGFR的结合以及抗体依赖性细胞毒性

Sato, Shigeki; Yilmaz, Neval; Arai, Sachiko; Sakai, Katsuya; Sato, Hiroki; Murase, Yuya; Ueda, Tsukasa; Koba, Hayato; Nanjo, Shigeki; Tambo, Yuichi; Kotani, Hiroshi; Fukuda, Koji; Taniguchi, Hiroaki; Amyot, Romain; Flechsig, Holger; Isozaki, Hideko; Matsumoto, Kunio; Yano, Seiji

Therapeutic Strategies to Overcome Payload Resistance of Trastuzumab Deruxtecan in HER2-Positive Cancers

克服 HER2 阳性癌症中曲妥珠单抗 Deruxtecan 有效载荷耐药性的治疗策略

Murase, Yuya; Nanjo, Shigeki; Arai, Sachiko; Kondo, Sota; Koba, Hayato; Liu, Yifeng; Fukuda, Koji; Sato, Shigeki; Kinoshita, Jun; Inaki, Noriyuki; Ueda, Tsukasa; Nomura, Shunichi; Tambo, Yuichi; Shimizu, Takahiro; Horie, Masafumi; Maeda, Daichi; Wong, Richard W; Hosomichi, Kazuyoshi; Kobayashi, Takafumi; Watanabe, Satoshi; Yamamura, Kenta; Ohkura, Noriyuki; Abo, Miki; Yano, Seiji

Ethical, legal, and social implications of AI-enabled digital therapeutics: A comparative analysis of risk-based regulatory frameworks in the European Union and Japan

人工智能赋能的数字疗法的伦理、法律和社会影响:欧盟和日本基于风险的监管框架的比较分析

Fukuda, Yasue; Fukuda, Koji

Role of clonal lineage analysis via next-generation sequencing in identifying the origin of multiple cancers and guiding treatment options

利用新一代测序技术进行克隆谱系分析在识别多种癌症起源和指导治疗方案选择中的作用

Shimoyachi, Rie; Takimoto, Aya; Yoshida, Taichi; Fukuda, Koji; Shimazu, Kazuhiro; Taguchi, Daiki; Kodama, Naoaki; Matsumoto, Tomohiro; Wakabayashi, Toshiki; Imai, Kazuhiro; Nanjyo, Hiroshi; Shibata, Hiroyuki

Relationship of nutritional or systemic inflammatory markers with efficacy of gemcitabine and cisplatin with or without durvalumab therapy for patients with unresectable or metastatic biliary tract cancer: a retrospective study

营养或全身炎症标志物与吉西他滨联合顺铂(含或不含度伐利尤单抗)治疗不可切除或转移性胆道癌患者疗效的关系:一项回顾性研究

Fukushi, Yayoi; Fujita, Kazuma; Akamine, Yumiko; Igarashi, Haruka; Sasaki, Katsuya; Fukuda, Koji; Shibata, Hiroyuki; Kikuchi, Masafumi

Early angiographic changes after hemostatic radiotherapy for gastric cancer bleeding, mentioning the mechanism and potential immediate effects of the treatment

胃癌出血止血放射治疗后早期血管造影变化,探讨其机制及治疗的潜在近期影响

Wada, Yuki; Konno, Motoko; Tozawa, Tomoki; Sato, Tomochika; Shinozaki, Tetsugaku; Kumagai, Satoshi; Takagi, Noriko; Fukuda, Koji; Shibata, Hiroyuki; Mori, Naoko

Case Report: Extended survival in KRAS-G12V NSCLC with leptomeningeal metastasis through integrated intrathecal chemotherapy and systemic therapies

病例报告:KRAS-G12V突变型非小细胞肺癌伴软脑膜转移患者通过鞘内化疗联合全身治疗延长生存期

Chen, Yun; Qin, Zhiquan; Zhan, Luying; Guo, Xinchang; Fukuda, Koji; Zhou, Qihao

Antiplatelets for Cardiovascular Disease in Non-valvular AF with Rivaroxaban: A Subanalysis of the EXPAND Study

利伐沙班用于治疗非瓣膜性房颤合并心血管疾病的抗血小板治疗:EXPAND 研究的亚组分析

Kaikita, Koichi; Uchiyama, Shinichiro; Atarashi, Hirotsugu; Inoue, Hiroshi; Kitazono, Takanari; Yamashita, Takeshi; Shimizu, Wataru; Ikeda, Takanori; Kamouchi, Masahiro; Fukuda, Koji; Origasa, Hideki; Shimokawa, Hiroaki

Familial adenomatous polyposis family with clustering of psychiatric disorders

家族性腺瘤性息肉病伴精神疾病聚集

Funaki, Masako; Noguchi, Atsuko; Ishikawa, Hayahito; Noutomi, Rie; Fukuda, Koji; Shimazu, Kazuhiro; Yoshida, Taichi; Taguchi, Daiki; Shinozaki, Hanae; Kodama, Naoaki; Mishima, Kazuo; Nanjo, Hiroshi; Takahashi, Tsutomu; Shibata, Hiroyuki